Effects of OROS-MPH Versus Dl-Amphetamine-XR on Driving Performance of ADHD Adolescents

Authors

  • J Gordon Millichap Northwestern University Feinberg School of Medicine

DOI:

https://doi.org/10.15844/pedneurbriefs-20-10-4

Keywords:

Dl-Amphetamine Salts, Adderall XR, OROS Methylphenidate

Abstract

Driving performance of 35 adolescent ADHD patients (19 boys/16 girls; mean age 17.8 years) on a driving simulator was compared while taking OROS methylphenidate (Concerta, 72 mg), mixed dl-amphetamine salts (Adderall XR, 30 mg), or placebo in a randomized, double-blind, crossover study at University of Virginia, Charlottesville.

Published

2006-10-01

Issue

Section

Cognitive Disorders